The Food and Drug Administration yesterday posted a list of COVID-19 antibody tests that will no longer be marketed because they have not been authorized for emergency use under its revised policy, or the manufacturer withdrew them from the list of tests under review for emergency use.

To help ensure COVID-19 antibody tests are trustworthy, the agency revised its guidance May 4 to recommend manufacturers request an emergency use authorization within 10 business days after they validate their test.

Related News Articles

Headline
The Centers for Disease Control and Prevention updated its page on COVID-19 transmission to clarify other types of spread beyond person to person, such as by…
Headline
The Food and Drug Administration yesterday updated guidance to spur wider availability of alcohol-based hand sanitizers during the COVID-19 pandemic. The…
Headline
The Health Resources and Services Administration today awarded $20.3 million to increase the number of fellows at accredited addiction medicine and addiction…
Headline
The Centers for Medicare & Medicaid Services yesterday implemented several new infection control actions to combat COVID-19 in nursing homes. One…
Headline
The AHA today asked the Department of Health and Human Services to distribute substantial additional emergency funds to hospitals and health systems in an…
Headline
An estimated 9.5% of U.S. residents, or 30.7 million people, lacked health insurance when surveyed in the first six months of 2019, according to preliminary…